60
Pelage Pharmaceuticals, Inc. raises $120M under Reg D
Company raise · Closed · LOS ANGELES, CA · Form D filed 2025-11-24
$50M+ raiseFirst raise on EDGAR
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Cathy Edward Friedman | Director |
| Nathan Edward Wheeler | Executive Officer |
| William Edward Lowry | Executive Officer, Director |
| Christina Edward Weng | Executive Officer |
| Daniel Gil | Executive Officer, Director |
| Richard Edward Heyman | Director |
Signed by Daniel Gil, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.